Detalhe da pesquisa
1.
Gastroenteropancreatic Neuroendocrine Tumors.
CA Cancer J Clin
; 68(6): 471-487, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295930
2.
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Int J Cancer
; 153(1): 164-172, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891979
3.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793718
4.
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 48(11): 3408-3421, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772332
5.
Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms.
J Natl Compr Canc Netw
; 20(1): 29-36, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433130
6.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(7): 839-868, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340212
7.
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
Br J Cancer
; 122(9): 1309-1314, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152503
8.
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.
Neuroendocrinology
; 110(5): 377-383, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31357193
9.
The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.
Neuroendocrinology
; 110(3-4): 234-245, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121586
10.
The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.
Oncologist
; 24(1): 54-61, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104288
11.
Are hemicolectomies justified for appendiceal neuroendocrine tumours smaller than 2 cm?
Lancet Oncol
; 24(2): 121-122, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640791
12.
Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).
Neuroendocrinology
; 107(1): 32-41, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29539613
13.
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
J Natl Compr Canc Netw
; 16(6): 693-702, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891520
14.
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(10): 1411-1422, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838862
15.
A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.
Invest New Drugs
; 33(1): 241-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25318437
16.
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
Neuroendocrinology
; 101(4): 274-88, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924937
17.
Neuroendocrine tumors, version 1.2015.
J Natl Compr Canc Netw
; 13(1): 78-108, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25583772
18.
Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation.
Cancer Control
; 22(1): 102-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25504284
19.
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.
Oncologist
; 19(9): 930-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25096997
20.
Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options.
Endocr Pract
; 20(2): 167-75, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24014009